Steven Almo
Directeur/Membre du Conseil chez New York Structural Biology Center, Inc.
Profil
Steven C.
Almo is the founder of Cue Biopharma, Inc. which was founded in 2014.
Currently, he is the Director at New York Structural Biology Center, Inc. and the Director at Institute For Protein Innovation, Inc.
Postes actifs de Steven Almo
| Sociétés | Poste | Début |
|---|---|---|
New York Structural Biology Center, Inc.
 New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Institute For Protein Innovation, Inc.
 Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - |
Anciens postes connus de Steven Almo
| Sociétés | Poste | Fin |
|---|---|---|
| CUE BIOPHARMA, INC. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CUE BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
New York Structural Biology Center, Inc.
New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Health Technology |
Institute For Protein Innovation, Inc.
Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Commercial Services |
